State Street Corporation has filed an amended Schedule 13G with the United States Securities and Exchange Commission (SEC) on March 31, 2024, indicating a change in its holdings of bluebird bio, Inc. common stock. The filing, categorized under Rule 13D-1(B), shows that State Street Corporation has shared voting power over 3,293,844 shares and shared dispositive power over 3,428,135 shares of bluebird bio. This represents a significant stake in the company, as the aggregate amount of shares beneficially owned by State Street Corporation constitutes more than five percent of bluebird bio's class of common stock. The filing asserts that the shares were acquired and are held in the ordinary course of business, not with the intent of changing or influencing the control of the issuer...Show More

State Street Corporation has filed an amended Schedule 13G with the United States Securities and Exchange Commission (SEC) on March 31, 2024, indicating a change in its holdings of bluebird bio, Inc. common stock. The filing, categorized under Rule 13D-1(B), shows that State Street Corporation has shared voting power over 3,293,844 shares and shared dispositive power over 3,428,135 shares of bluebird bio. This represents a significant stake in the company, as the aggregate amount of shares beneficially owned by State Street Corporation constitutes more than five percent of bluebird bio's class of common stock. The filing asserts that the shares were acquired and are held in the ordinary course of business, not with the intent of changing or influencing the control of the issuer, nor in connection with any transaction that has such purpose or effect. The subsidiaries of State Street Corporation listed in the filing as beneficial owners include SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, State Street Global Advisors Limited, and State Street Global Advisors Trust Company, all classified as Investment Advisors (IA).